帕金森病患者面部表情减退研究进展

doi:10.12114/j.issn.1007-9572.2022.0245

摘要/Abstract

摘要： 帕金森病显著的临床特征之一是面部表情减退，主要表现为自主性、情绪性等面部表情受损，且通常是双侧对称的。近年来有大量研究阐述了帕金森病表情减退发生的相关机制，包括含基底核区功能障碍、面部情绪识别功能缺陷、认知功能障碍等因素，但具体的病理、生理机制尚未明确。表情减退与帕金森病进程密切相关，因此，对表情减退进行科学地量化与评估对于帕金森病的诊治具有重要意义。此外，关于其治疗方案也仍然存在争议。本文就帕金森病患者表情减退的临床表现、发生机制、治疗研究进展做一综述。

关键词: 帕金森病, 面部表情, 表情减退, 体征和症状, 治疗

Abstract:

Hypomimia is one prominent clinical symptom of Parkinson's disease (PD) , which is mainly characterized by a loss or reduction of voluntary, emotional and other facial expressions, and usually appears bilaterally and symmetrically. Factors associated with hypomimia in PD have been extensively studied recently, including basal ganglia dysfunction, facial emotion recognition deficit, and cognitive impairment, but the specific pathophysiological mechanism is still unclear. Hypomimia strongly correlates with the progression of PD, so scientific quantification and evaluation of hypomimia will be of great significance to the diagnosis and treatment of PD. Besides that, there is still controversy over its treatment plan. We reviewed the latest developments in clinical presentations, pathogenesis and treatment of hypomimia in PD.

Key words: Parkinson disease, Facial expression, Hypomimia, Signs and symptoms mechanism, Therapy

黄根,曹惠敏,余刚. 帕金森病患者面部表情减退研究进展[J]. 中国全科医学, 2022, 25(20): 2558-2562. DOI: 10.12114/j.issn.1007-9572.2022.0245.
Gen HUANG,Huimin CAO,Gang YU. Novel Developments in Hypomimia in Parkinson's Disease[J]. Chinese General Practice, 2022, 25(20): 2558-2562. DOI: 10.12114/j.issn.1007-9572.2022.0245.

参考文献 48

[1]	MASON A R，ZIEMANN A，FINKBEINER S. Targeting the low-hanging fruit of neurodegeneration[J]. Neurology，2014，83（16）：1470-1473. DOI：10.1212/WNL.0000000000000894.
[2]	HOMAYOUN H. Parkinson disease[J]. Ann Intern Med，2018，169（5）：ITC33-48. DOI：10.7326/AITC201809040.
[3]	DICKSON D W，BRAAK H，DUDA J E，et al. Neuropathological assessment of Parkinson's disease：refining the diagnostic criteria[J]. Lancet Neurol，2009，8（12）：1150-1157. DOI：10.1016/S1474-4422(09)70238-8.
[4]	SCHILDER J C，OVERMARS S S，MARINUS J，et al. The terminology of akinesia，bradykinesia and hypokinesia：Past，present and future[J]. Parkinsonism Relat Disord，2017，37：27-35. DOI：10.1016/j.parkreldis.2017.01.010.
[5]	BOLOGNA M，PAPARELLA G，FASANO A，et al. Evolving concepts on bradykinesia[J]. Brain，2020，143（3）：727-750. DOI：10.1093/brain/awz344.
[6]	BOLOGNA M，FABBRINI G，MARSILI L，et al. Facial bradykinesia[J]. J Neurol Neurosurg Psychiatry，2013，84（6）：681-685. DOI：10.1136/jnnp-2012-303993.
[7]	AGOSTINO R，BOLOGNA M，DINAPOLI L，et al. Voluntary，spontaneous，and reflex blinking in Parkinson's disease[J]. Mov Disord，2008，23（5）：669-675. DOI：10.1002/mds.21887.
[8]	MARSILI L，AGOSTINO R，BOLOGNA M，et al. Bradykinesia of posed smiling and voluntary movement of the lower face in Parkinson's disease[J]. Parkinsonism Relat Disord，2014，20（4）：370-375. DOI：10.1016/j.parkreldis.2014.01.013.
[9]	SIMONS G，PASQUALINI M C，REDDY V，et al. Emotional and nonemotional facial expressions in people with Parkinson's disease[J]. J Int Neuropsychol Soc，2004，10（4）：521-535. DOI：10.1017/S135561770410413X.
[10]	PHILLIPS O，D'ABREU A，FRIEDMAN J H，et al. Recognising hemihypomimia as a mimic of 'facial weakness'[J]. J Neurol Neurosurg Psychiatry，2020，91（12）：1357-1358. DOI：10.1136/jnnp-2020-323201.
[11]	PANICHELLI B S，SPITZ M. Hemihypomimia：an atypical and interesting feature of Parkinson's disease[J]. Arq Neuropsiquiatr，2021，79（9）：853. DOI：10.1590/0004-282X-ANP-2020-0461.
[12]	KURTIS M，GASCA C，MAYCAS-CEPEDA T，et al. PARKMIM：a transversal pilot study on hemihypomimia in Parkinson disease[J]. Movement Disorders，2019，34：S914-914.
[13]	RICCIARDI L，VISCO-COMANDINI F，ERRO R，et al. Emotional facedness in Parkinson's disease[J]. J Neural Transm （Vienna），2018，125（12）：1819-1827. DOI：10.1007/s00702-018-1945-6.
[14]	CATTANEO L，PAVESI G. The facial motor system[J]. Neurosci Biobehav Rev，2014，38：135-159. DOI：10.1016/j.neubiorev.2013.11.002.
[15]	NESHIGE S，YAMADA H，MARUYAMA H. Emotional facial paresis in temporal lobe epilepsy[J]. Intern Med，2021，60（16）：2705-2706. DOI：10.2169/internalmedicine.6970-20.
[16]	KAMINER J，POWERS A S，HORN K G，et al. Characterizing the spontaneous blink generator：an animal model[J]. J Neurosci，2011，31（31）：11256-11267. DOI：10.1523/JNEUROSCI.6218-10.2011.
[17]	CALABRESI P，PICCONI B，TOZZI A，et al. Direct and indirect pathways of basal ganglia：a critical reappraisal[J]. Nat Neurosci，2014，17（8）：1022-1030. DOI：10.1038/nn.3743.
[18]	RICCIARDI L，DE ANGELIS A，MARSILI L，et al. Hypomimia in Parkinson's disease：an axial sign responsive to levodopa[J]. Eur J Neurol，2020，27（12）：2422-2429. DOI：10.1111/ene.14452.
[19]	ARMSTRONG M J，OKUN M S. Diagnosis and treatment of parkinson disease：a review[J]. JAMA，2020，323（6）：548-560. DOI：10.1001/jama.2019.22360.
[20]	BOLOGNA M，GUERRA A，PAPARELLA G，et al. Neurophysiological correlates of bradykinesia in Parkinson's disease[J]. Brain，2018，141（8）：2432-2444. DOI：10.1093/brain/awy155.
[21]	HU X，JIANG Y，JIANG X，et al. Altered functional connectivity density in subtypes of Parkinson's disease[J]. Front Hum Neurosci，2017，11：458. DOI：10.3389/fnhum.2017.00458.
[22]	BOSTAN A C，STRICK P L. The basal ganglia and the cerebellum：nodes in an integrated network[J]. Nat Rev Neurosci，2018，19（6）：338-350. DOI：10.1038/s41583-018-0002-7.
[23]	DE ALMEIDA MARCELINO A L，HORN A，KRAUSE P，et al. Subthalamic neuromodulation improves short-term motor learning in Parkinson's disease[J]. Brain，2019，142（8）：2198-2206. DOI：10.1093/brain/awz152.
[24]	CONTE A，FERRAZZANO G，BELVISI D，et al. Somatosensory temporal discrimination in Parkinson's disease，dystonia and essential tremor：Pathophysiological and clinical implications[J]. Clin Neurophysiol，2018，129（9）：1849-1853. DOI：10.1016/j.clinph.2018.05.024.
[25]	YTTRI E A，DUDMAN J T. A proposed circuit computation in basal ganglia：history-dependent gain[J]. Mov Disord，2018，33（5）：704-716. DOI：10.1002/mds.27321.
[26]	KALAMPOKINI S，LYROS E，LULEY M，et al. Facial emotion recognition in Parkinson's disease：association with age and olfaction[J]. J Clin Exp Neuropsychol，2018，40（3）：274-284. DOI：10.1080/13803395.2017.1341470.
[27]	CHUANG Y H，TAN C H，SU H C，et al. Hypomimia may influence the facial emotion recognition ability in patients with Parkinson's disease[J]. J Parkinsons Dis，2022，12（1）：185-197. DOI：10.3233/JPD-212830.
[28]	WABNEGGER A，ILLE R，SCHWINGENSCHUH P，et al. Facial emotion recognition in Parkinson's disease：an fMRI investigation[J]. PLoS One，2015，10（8）：e0136110. DOI：10.1371/journal.pone.0136110.
[29]	MURRAY R J，BROSCH T，SANDER D. The functional profile of the human amygdala in affective processing：insights from intracranial recordings[J]. Cortex，2014，60：10-33. DOI：10.1016/j.cortex.2014.06.010.
[30]	PÉRON J，FRÜHHOLZ S，VÉRIN M，et al. Subthalamic nucleus：a key structure for emotional component synchronization in humans[J]. Neurosci Biobehav Rev，2013，37（3）：358-373. DOI：10.1016/j.neubiorev.2013.01.001.
[31]	MAYCAS-CEPEDA T，LOPEZ-RUIZ P，FELIZ-FELIZ C，et al. Hypomimia in Parkinson's disease：what is it telling us?[J]. Front Neurol，2020，11：603582. DOI：10.3389/fneur.2020.603582.
[32]	MATTAVELLI G，BARVAS E，LONGO C，et al. Facial expressions recognition and discrimination in Parkinson's disease[J]. J Neuropsychol，2021，15（1）：46-68. DOI：10.1111/jnp.12209.
[33]	DAN R，RUZICKA F，BEZDICEK O，et al. Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson's disease[J]. Eur Neuropsychopharmacol，2019，29（11）：1258-1272. DOI：10.1016/j.euroneuro.2019.09.003
[34]	RICCIARDI L，VISCO-COMANDINI F，ERRO R，et al. Facial emotion recognition and expression in Parkinson's disease：an emotional mirror mechanism?[J]. PLoS One，2017，12（1）：e0169110. DOI：10.1371/journal.pone.0169110.
[35]	RICCIARDI L，BOLOGNA M，MORGANTE F，et al. Reduced facial expressiveness in Parkinson's disease：a pure motor disorder?[J]. J Neurol Sci，2015，358（1-2）：125-130. DOI：10.1016/j.jns.2015.08.1516.
[36]	GASCA-SALAS C，URSO D. Association between hypomimia and mild cognitive impairment in de novo Parkinson's disease patients[J]. Can J Neurol Sci，2020，47（6）：855-857. DOI：10.1017/cjn.2020.93.
[37]	PAGONABARRAGA J，KULISEVSKY J，STRAFELLA A P，et al. Apathy in Parkinson's disease：clinical features，neural substrates，diagnosis，and treatment[J]. The Lancet Neurology，2015，14（5）：518-531. DOI：10.1016/S1474-4422(15)00019-8.
[38]	ASSOGNA F，PELLICANO C，SAVINI C，et al. Drug choices and advancements for managing depression in Parkinson's disease[J]. Curr Neuropharmacol，2020，18（4）：277-287. DOI：10.2174/1570159X17666191016094857.
[39]	BOLOGNA M，PAPARELLA G. Pathophysiology of rigidity in Parkinson's disease：another step forward[J]. Clin Neurophysiol，2020，131（8）：1971-1972. DOI：10.1016/j.clinph.2020.05.013.
[40]	SU G，LIN B，YIN J，et al. Detection of hypomimia in patients with Parkinson's disease via smile videos[J]. Ann Transl Med，2021，9（16）：1307. DOI：10.21037/atm-21-3457.
[41]	ALI M R，MYERS T，WAGNER E，et al. Facial expressions can detect Parkinson's disease：preliminary evidence from videos collected online[J]. NPJ Digit Med，2021，4（1）：129. DOI：10.1038/s41746-021-00502-8.
[42]	AVNER A，STEVEN G，CAMILLA K，et al. Automated computer vision assessment of hypomimia in Parkinson disease：proof-of-principle pilot study[J]. Journal of Medical Internet Research，2021，23（2）：e21037. DOI：10.2196/21037.
[43]	ELENA P，DANIELE V，ALBERTO C，et al. Quantitative evaluation of hypomimia in parkinson's disease：a face tracking approach[J]. Sensors，2022，22（4）：1358. DOI：10.3390/s22041358.
[44]	STROTZER Q D，ANTHOFER J M，FALTERMEIER R，et al. Deep brain stimulation：connectivity profile for bradykinesia alleviation[J]. Ann Neurol，2019，85（6）：852-864. DOI：10.1002/ana.25475.
[45]	WAGENBRETH C，KUEHNE M，HEINZE H J，et al. Deep brain stimulation of the subthalamic nucleus influences facial emotion recognition in patients with Parkinson's disease：a review[J]. Front Psychol，2019，10：2638. DOI：10.3389/fpsyg.2019.02638.
[46]	MARNEWECK M，HAMMOND G. Voluntary control of facial musculature in Parkinson's disease[J]. J Neurol Sci，2014，347（1-2）：332-336. DOI：10.1016/j.jns.2014.11.003.
[47]	RICCIARDI L，BAGGIO P，RICCIARDI D，et al. Rehabilitation of hypomimia in Parkinson's disease：a feasibility study of two different approaches[J]. Neurol Sci，2016，37（3）：431-436. DOI：10.1007/s10072-015-2421-9.
[48]	DUMER AI，OSTER H，MCCABE D，et al. Effects of the Lee Silverman Voice Treatment（LSVT® LOUD） on hypomimia in Parkinson's disease[J]. J Int Neuropsychol Soc，2014，20（3）：302-312. DOI：10.1017/S1355617714000046.